Register of Members and Share Transfer books of the company will remain closed from 19th September 2024 to 25th September 2024 ( both days inclusive ) to ascertain the entitlement of Dividend and for 37th Annual General Meeting of the Company .

pdf

Bal Pharma Ltd.

12 Aug 2024

122.23

12.82%

Result

BAL PHARMA LTD. - 524824 - Unaudited Financial Results For The Quarter Ended 30.06.2024.

BSE India

Taken on record and Approved the Unaudited financial results of the Company for the quarter ended 30.06.2024.

pdf

Bal Pharma Ltd.

12 Aug 2024

122.23

12.82%

Board Meeting

BAL PHARMA LTD. - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting

BSE India

Inter alia 1.Taken on record and approved the Unaudited financial results of the Company for the quarter ended 30.06.2024. 2. Convened 37th Annual General Meeting of the Company on 25th September 2024. 3. Decided to close the Register of Members and Share transfer books of the Company from 19.09.2024 to 25.09.2024(both days inclusive ) to ascertain the entitlement of Dividend and for 37th AGM. 4.Approved the re-classification of promoter share holding subject to the approval of shareholders.

pdf

Bal Pharma Ltd.

26 Jul 2024

122.23

12.82%

Board Meeting

BAL PHARMA LTD. - 524824 - Board Meeting Intimation for Inter Alia Take On Record And …

BSE India

BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 ,inter alia, to consider and approve 1. Un-Audited financial Results for the quarter ended 30.06.2024. 2.To review the requests of the promoters for reclassification. 3. To convene 37th Annual General Meeting of the Company. 4. To Decide on Book Closure dates. 5. Other AGM related matters. 6. Allotment of equity shares to the employees of the Company upon conversion of stock options.

pdf

Bal Pharma Ltd.

16 Jul 2024

122.23

12.82%

Corp. Note

BAL PHARMA LTD. - 524824 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Disclosure of details of loss of share certificates as per regulation 39(3) of SEBI (LODR) Regulations,2015.

pdf

Bal Pharma Ltd.

04 Jul 2024, 12:53PM

122.23

12.82%

Company Update

BAL PHARMA LTD. - 524824 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

We are submitting the confirmation of compliance with Regulation 74(5) SEBI(DP) Regulations, for the quarter ended 30.06.2024.

pdf

Bal Pharma Ltd.

28 Jun 2024

122.23

12.82%

Company Update

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

We would like to inform the exchanges that Dr.C.V Srinivas ( DIN# 04495304) Independent Director of the Company has completed his tenure of five years as Independent Director of the Company and he ceases to be on the Board of the Company w.e.f 28.06.2024.

pdf

No results found

Is Bal Pharma Ltd. worth buying?

52 Votes:

Buy 76.92%

Sell 13.46%

Hold 9.62%

56.58% Gain from 52W Low

High volume+gain today

Bal Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Bal Pharma Ltd. from all sources in a single place.